1. Home
  2. CAKE vs SUPN Comparison

CAKE vs SUPN Comparison

Compare CAKE & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAKE
  • SUPN
  • Stock Information
  • Founded
  • CAKE 1972
  • SUPN 2005
  • Country
  • CAKE United States
  • SUPN United States
  • Employees
  • CAKE N/A
  • SUPN N/A
  • Industry
  • CAKE Restaurants
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAKE Consumer Discretionary
  • SUPN Health Care
  • Exchange
  • CAKE Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • CAKE 2.5B
  • SUPN 1.9B
  • IPO Year
  • CAKE 1992
  • SUPN 2012
  • Fundamental
  • Price
  • CAKE $48.05
  • SUPN $36.62
  • Analyst Decision
  • CAKE Hold
  • SUPN Hold
  • Analyst Count
  • CAKE 16
  • SUPN 1
  • Target Price
  • CAKE $47.33
  • SUPN $36.00
  • AVG Volume (30 Days)
  • CAKE 1.1M
  • SUPN 359.6K
  • Earning Date
  • CAKE 02-19-2025
  • SUPN 02-25-2025
  • Dividend Yield
  • CAKE 2.28%
  • SUPN N/A
  • EPS Growth
  • CAKE 52.49
  • SUPN 130.79
  • EPS
  • CAKE 2.64
  • SUPN 1.07
  • Revenue
  • CAKE $3,537,745,000.00
  • SUPN $651,972,000.00
  • Revenue This Year
  • CAKE $5.95
  • SUPN $7.82
  • Revenue Next Year
  • CAKE $5.32
  • SUPN N/A
  • P/E Ratio
  • CAKE $17.98
  • SUPN $33.80
  • Revenue Growth
  • CAKE 2.39
  • SUPN 6.79
  • 52 Week Low
  • CAKE $31.24
  • SUPN $25.53
  • 52 Week High
  • CAKE $52.10
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • CAKE 51.70
  • SUPN 53.31
  • Support Level
  • CAKE $46.84
  • SUPN $35.73
  • Resistance Level
  • CAKE $48.64
  • SUPN $37.34
  • Average True Range (ATR)
  • CAKE 1.35
  • SUPN 1.20
  • MACD
  • CAKE -0.30
  • SUPN 0.00
  • Stochastic Oscillator
  • CAKE 37.30
  • SUPN 73.40

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: